C3.ai(US:AI) GlobeNewswire News Roomยท2025-09-08 10:40Core Viewpoint - The C3.ai class action lawsuit alleges that the company and its executives misled investors regarding the company's revenue outlook and growth potential, particularly in relation to CEO Thomas M. Siebel's health issues, which ultimately led to a significant drop in stock price following disappointing financial results [1][4][5]. Group 1: Lawsuit Details - The lawsuit, titled Liggett v. C3.ai, Inc., is pending in the Northern District of California and seeks to represent purchasers of C3.ai securities [1]. - The complaint claims that C3.ai's optimistic growth reports were misleading and overly reliant on the CEO's health and effectiveness [4]. - Following the announcement of disappointing preliminary financial results for Q1 FY 2026 and a reduction in revenue guidance, C3.ai's stock price fell by more than 25% [5]. Group 2: Financial Context - C3.ai announced poor sales results and lowered guidance due to "the reorganization with new leadership" and the CEO's health issues [5]. - The lawsuit highlights that the company's financial outlook was not as robust as presented, raising concerns about its profitability and growth trajectory [4]. Group 3: Legal Process - Investors who purchased C3.ai securities during the class period can seek to be appointed as lead plaintiff in the lawsuit, which allows them to act on behalf of other class members [6]. - The lead plaintiff can choose a law firm to represent the class, and participation as lead plaintiff does not affect the ability to share in any potential recovery [6]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [7]. - The firm has a strong track record in securing monetary relief for investors, ranking 1 in ISS Securities Class Action Services for four out of the last five years [7].